AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
137 hedge funds and large institutions have $354M invested in Aerie Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 53 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less capital invested
Capital invested by funds: $437M → $354M (-$83.3M)
Holders
137
Holding in Top 10
–
Calls
$100K
Puts
$9K
Top Buyers
| 1 | +$9.24M | |
| 2 | +$5.4M | |
| 3 | +$4.12M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.98M |
| 5 |
Walleye Capital
New York
|
+$2.72M |
Top Sellers
| 1 | -$8.68M | |
| 2 | -$7.18M | |
| 3 | -$6.61M | |
| 4 |
Millennium Management
New York
|
-$4.43M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$2.92M |